• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    PerkinElmer (NY: PKI )

    N/A UNCHANGED
    Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about PerkinElmer

    < Previous 1 2 3 Next >
    Revvity Announces Financial Results for the First Quarter of 2023
    From Revvity, Inc.
    Via Business Wire
    Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
    From Revvity, Inc.
    Via Business Wire
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer to Present at Upcoming Investor Conferences
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer to Present at J.P. Morgan Healthcare Conference
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer to Present at 2022 Stifel Healthcare Conference
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Announces Financial Results for the Third Quarter of 2022
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
    From PerkinElmer
    Via Business Wire
    PerkinElmer to Present at Upcoming Investor Conferences
    From PerkinElmer Inc.
    Via Business Wire
    PerkinElmer Announces Finance Leadership Transition
    From PerkinElmer, Inc.
    Via Business Wire
    New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
    From New Mountain Capital
    Via Business Wire
    PerkinElmer Announces Financial Results for the Second Quarter of 2022
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
    From PerkinElmer, Inc.
    Via Business Wire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.